Axim Biotechnologies, Inc. (AXIM): Cash & Equivalents
Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$47.3K
As of 2022-12-31
-54.8%
3-year compound annual growth
-53.0%
5-year compound annual growth
+9.5%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $47.3K | -89.6% | 2023-04-17, Balance as of period end |
| 2021-12-31 | $453.0K | -0.9% | 2023-04-17, Balance as of period end |
| 2020-12-31 | $457.2K | -10.6% | 2022-04-19, Balance as of period end |
| 2019-12-31 | $511.6K | -71.7% | 2021-04-26, Balance as of period end |
| 2018-12-31 | $1.81M | -12.3% | 2020-05-20, Balance as of period end |
| 2017-12-31 | $2.06M | +188.5% | 2019-04-08, Balance as of period end |
| 2016-12-31 | $713.3K | +431.7% | 2018-03-15, Balance as of period end |
| 2015-12-31 | $134.2K | -79.7% | 2016-04-18, Balance as of period end |
| 2014-12-31 | $661.1K | n/m | 2016-04-18, Balance as of period end |
| 2013-12-31 | $127 | -99.3% | 2015-04-14, Balance as of period end |
| 2012-12-31 | $19.1K | -17.3% | 2014-03-04, Balance as of period end |
| 2011-12-31 | $23.1K | n/a | 2013-04-15, Balance as of period end |
| 2010-12-31 | $0 | n/a | 2012-05-01, Balance as of period end |